ADAM17 and neoplasm: The increased pADAM17 activity in LAC patients was not a consequence of elevated ADAM17 expression, since ADAM17 mRNA and protein (pro/mature) levels were unchanged in tumor versus non‐tumor tissues in LAC patient cohorts (Fig EV4B and C).